Related Experiment Video
Updated: Jun 14, 2025

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
TET3 Protein Represses Proliferation of the MG-63 Human Osteosarcoma Cell Line by Regulating DNA Demethylation: an
Shijun Hang1,2, Bingjun Cui3, Aichun Wei4,5
1Department of Orthopedics, Haian Hospital of Traditional Chinese Medicine, Haian, China.
Abstract:
Recent studies have highlighted the significant role of 5-hydroxymethylcytosine (5hmC) in carcinogenesis. However, the specific role of 5hmC in osteosarcoma (OS) remains largely unexplored. The-re-fore, this study aimed to investigate the function of 5hmC and TET3 in OS. In this study, we found a decreased total level of 5hmC in OS tissues. The expression of the TET3 protein was also decreased in OS. Importantly, the decreased levels of TET3 were associated with a decreased disease-free survival (DFS) rate in patients. To investigate the role of TET3 and 5hmC in OS, we manipulated the levels of TET3 in MG-63 cells. Silencing TET3 in these cells resulted in a twofold increase in proliferation. Additio-nally, the level of 5hmC decreased in these cells. Con-versely, over-expression of TET3 in MG-63 cells led to the expected inhibition of proliferation and invasion, accompanied by an increase in 5hmC levels. In conclusion, both 5hmC and TET3 protein levels were decreased in OS. Additionally, the over-expression of TET3 inhibited the proliferation of MG-63 cells, while the suppression of TET3 had the opposite effect. These findings suggest that decreased levels of 5hmC and TET3 may serve as potential markers for OS.
Insights
Levels of 5-hydroxymethylcytosine (5hmC) and TET3 protein are decreased in osteosarcoma (OS). Lower TET3 levels correlate with reduced survival, and manipulating TET3 affects cancer cell proliferation, suggesting 5hmC and TET3 as potential OS biomarkers.
Area of Science:
- Epigenetics
- Oncology
- Biochemistry
Background:
- 5-hydroxymethylcytosine (5hmC) plays a role in various cancers.
- The specific function of 5hmC and TET3 in osteosarcoma (OS) is not well understood.
Purpose of the Study:
- To investigate the role and levels of 5hmC and TET3 in osteosarcoma.
- To determine the potential of 5hmC and TET3 as biomarkers for OS.
Main Methods:
- Quantification of 5hmC and TET3 protein levels in OS tissues.
- Manipulation of TET3 expression (silencing and overexpression) in MG-63 osteosarcoma cells.
- Assessment of cell proliferation and invasion rates following TET3 level changes.
Main Results:
- Osteosarcoma tissues exhibited decreased levels of both 5hmC and TET3 protein.
- Reduced TET3 expression was associated with a lower disease-free survival (DFS) rate in patients.
- Silencing TET3 in MG-63 cells increased proliferation and decreased 5hmC levels.
- Overexpressing TET3 inhibited proliferation and invasion while increasing 5hmC levels.
Conclusions:
- Both 5hmC and TET3 protein levels are significantly decreased in osteosarcoma.
- TET3 plays a crucial role in regulating osteosarcoma cell proliferation and invasion.
- Decreased 5hmC and TET3 may serve as potential diagnostic and prognostic biomarkers for osteosarcoma.
Related Concept Videos
Abnormal Proliferation
Epigenetic Regulation
Negative Regulator Molecules
Replicative Cell Senescence
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...

